2009
DOI: 10.1038/cmi.2009.53
|View full text |Cite
|
Sign up to set email alerts
|

Paradoxical Roles of IL-4 in Tumor Immunity

Abstract: Interleukin (IL)-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
96
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 125 publications
(97 citation statements)
references
References 67 publications
1
96
0
Order By: Relevance
“…Among these cytokines, IL-4 has been shown to have both protective as well as suppressive effect of antitumor immune responses, depending on the source of this cytokine and also the time of its production (30). Recently, it has been reported that IL-4 can downregulate the NKG2D expression on human CD8 + T as well as mouse NK cells, resulting in suppression of antitumor immune responses (31,32).…”
Section: G D T Cells Have Many Unique Features and Functions (1-6)mentioning
confidence: 99%
“…Among these cytokines, IL-4 has been shown to have both protective as well as suppressive effect of antitumor immune responses, depending on the source of this cytokine and also the time of its production (30). Recently, it has been reported that IL-4 can downregulate the NKG2D expression on human CD8 + T as well as mouse NK cells, resulting in suppression of antitumor immune responses (31,32).…”
Section: G D T Cells Have Many Unique Features and Functions (1-6)mentioning
confidence: 99%
“…It is very likely that the effects of IL-4 are dependent on the types of its source and target cells, the concentration and time of expression, the availability of the signaling components and regulatory pathways in target cells, and other interacting microenvironmental factors; some of these aspects have been previously reviewed. 91,92 Here we summarize the current knowledge of the opposing anti-and pro-tumor effects which IL-4 exerts on different target cells (Fig. 3).…”
Section: Opposing Effects Of Il-4 On Tumor Growthmentioning
confidence: 99%
“…In our results, IL4 was seen to be involved with complete remission when treated with any of the three therapies: mitotic inhibitors, anti-angiogenesis and antimetabolite. This was validated further with the experimental evidence of overexpressed IL4R contributing towards remission in lung cancer patients [97].…”
Section: Survival Analysis and Biomarkersmentioning
confidence: 99%